Literature DB >> 31440777

Multidisciplinary Approach to Treating Severe Acute Pancreatitis in a Low-Volume Hospital.

Alvaro Robin-Lersundi1, Ana Abella Alvarez2, Carlos San Miguel Mendez3, Almudena Moreno Elalo-Olaso3, Arturo Cruz Cidoncha3, Asunción Aguilera Velardo3, Federico Gordo Vidal2,4, Miguel-Angel García-Ureña3,5.   

Abstract

BACKGROUND: Up to 25% of patients with acute pancreatitis develop severe complications and are classified as severe pancreatitis with a high death rate. To improve outcomes, patients may require interventional measures including surgical procedures. Multidisciplinary approach and best practice guidelines are important to decrease mortality.
METHODS: We have conducted a retrospective analysis from a prospectively maintained database in a low-volume hospital. A total of 1075 patients were attended for acute pancreatitis over a ten-year period. We have analysed 44 patients meeting the criteria for severe acute pancreatitis and for intensive care unit (ICU) admittance. Demographics and clinical data were analysed. Patients were treated according to international guidelines and a multidisciplinary flowchart for acute pancreatitis and a step-up approach for pancreatic necrosis.
RESULTS: Forty-four patients were admitted to the ICU due to severe acute pancreatitis. Twenty-five patients needed percutaneous drainage of peri-pancreatic or abdominal fluid collections or cholecystitis. Eight patients underwent endoscopic retrograde cholangiopancreatography for choledocholithiasis and biliary sepsis or pancreatic leakage, and one patient received endoscopic trans-gastric endoscopic prosthesis for pancreatic necrosis. Sixteen patients underwent surgery: six patients for septic abdomen, four patients for pancreatic necrosis and two patients due to abdominal compartment syndrome. Four patients had a combination of surgical procedures for pancreatic necrosis and for abdominal compartment syndrome. Overall mortality was 9.1%.
CONCLUSION: Severe acute pancreatitis represents a complex pathology that requires a multidisciplinary approach. Establishing best practice treatments and evidence-based guidelines for severe acute pancreatitis may improve outcomes in low-volume hospitals.

Entities:  

Mesh:

Year:  2019        PMID: 31440777     DOI: 10.1007/s00268-019-05114-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  37 in total

Review 1.  The incidence and aetiology of acute pancreatitis across Europe.

Authors:  Stephen E Roberts; Sian Morrison-Rees; Ann John; John G Williams; Tim H Brown; David G Samuel
Journal:  Pancreatology       Date:  2017-01-19       Impact factor: 3.996

2.  Impact of hospital volume on outcomes in acute pancreatitis: a study using a nationwide administrative database.

Authors:  Tsuyoshi Hamada; Hideo Yasunaga; Yousuke Nakai; Hiroyuki Isayama; Hiromasa Horiguchi; Kiyohide Fushimi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2013-10-11       Impact factor: 7.527

3.  Management of acute pancreatitis in Japan: Analysis of nationwide epidemiological survey.

Authors:  Shin Hamada; Atsushi Masamune; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

4.  Minimal access retroperitoneal pancreatic necrosectomy: improvement in morbidity and mortality with a less invasive approach.

Authors:  Michael G T Raraty; Christopher M Halloran; Susanna Dodd; Paula Ghaneh; Saxon Connor; Jonathan Evans; Robert Sutton; John P Neoptolemos
Journal:  Ann Surg       Date:  2010-05       Impact factor: 12.969

5.  A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome.

Authors:  Hjalmar C van Santvoort; Olaf J Bakker; Thomas L Bollen; Marc G Besselink; Usama Ahmed Ali; A Marjolein Schrijver; Marja A Boermeester; Harry van Goor; Cornelis H Dejong; Casper H van Eijck; Bert van Ramshorst; Alexander F Schaapherder; Erwin van der Harst; Sijbrand Hofker; Vincent B Nieuwenhuijs; Menno A Brink; Philip M Kruyt; Eric R Manusama; George P van der Schelling; Tom Karsten; Eric J Hesselink; Cornelis J van Laarhoven; Camiel Rosman; Koop Bosscha; Ralph J de Wit; Alexander P Houdijk; Miguel A Cuesta; Peter J Wahab; Hein G Gooszen
Journal:  Gastroenterology       Date:  2011-07-08       Impact factor: 22.682

Review 6.  Abdominal compartment syndrome in acute pancreatitis: a systematic review.

Authors:  Sandra van Brunschot; Anne Julia Schut; Stefan A Bouwense; Marc G Besselink; Olaf J Bakker; Harry van Goor; Sijbrand Hofker; Hein G Gooszen; Marja A Boermeester; Hjalmar C van Santvoort
Journal:  Pancreas       Date:  2014-07       Impact factor: 3.327

7.  Endoscopic transgastric vs surgical necrosectomy for infected necrotizing pancreatitis: a randomized trial.

Authors:  Olaf J Bakker; Hjalmar C van Santvoort; Sandra van Brunschot; Ronald B Geskus; Marc G Besselink; Thomas L Bollen; Casper H van Eijck; Paul Fockens; Eric J Hazebroek; Rian M Nijmeijer; Jan-Werner Poley; Bert van Ramshorst; Frank P Vleggaar; Marja A Boermeester; Hein G Gooszen; Bas L Weusten; Robin Timmer
Journal:  JAMA       Date:  2012-03-14       Impact factor: 56.272

8.  Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus.

Authors:  Peter A Banks; Thomas L Bollen; Christos Dervenis; Hein G Gooszen; Colin D Johnson; Michael G Sarr; Gregory G Tsiotos; Santhi Swaroop Vege
Journal:  Gut       Date:  2012-10-25       Impact factor: 23.059

9.  Serial evaluation of the SOFA score is reliable for predicting mortality in acute severe pancreatitis.

Authors:  Yu-San Tee; Hsin-Yueh Fang; I-Ming Kuo; Yann-Sheng Lin; Song-Fong Huang; Ming-Chin Yu
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.817

Review 10.  Improving detection of patient deterioration in the general hospital ward environment.

Authors:  Jean-Louis Vincent; Sharon Einav; Rupert Pearse; Samir Jaber; Peter Kranke; Frank J Overdyk; David K Whitaker; Federico Gordo; Albert Dahan; Andreas Hoeft
Journal:  Eur J Anaesthesiol       Date:  2018-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.